Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Monosodium Citrate | HCID 23666341 | — |
| Edukt | HCID 131734730 | HCID 131734730 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Produkt | Tofacitinib Citrate | HCID 10174505 | 89,3% |
Reaktionsschritte
Amorphous tofacitinib hydrobromide (0.55 g) was dissolved in water (6 mL). The solution was treated with solid monosodium citrate (0.40 g, 1.69 mmol) and the resulting white suspension was stirred for 16 hours at 25° C. The suspension was filtered, washed with water (2×5 mL) and air-dried for 16 hours at 25° C. to yield 0.63 g of tofacitinib citrate as a white solid.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US09260438B2 |
|---|
| Quelldatensatz | uspto-grants-2016_02 |
|---|
| ORD ID | ord-749e280bbddb45d38834f9f5890e8c66 |
|---|
| Quellennotiz | uspto-grants-2016_02 |
|---|